MedPath

Self Testing Own Kidneys (STOK) Study

Not Applicable
Completed
Conditions
Specialty: Renal Disorders, Primary sub-specialty: Renal Disorders
Health Category: Renal and Urogenital
Disease/Condition: Other disorders of kidney and ureter
Urological and Genital Diseases
Registration Number
ISRCTN68116915
Lead Sponsor
South Tees Hospitals NHS Foundation Trust
Brief Summary

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37284676/ (added 08/06/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
15
Inclusion Criteria

1. Participant criteria - adequate cognitive and functional ability to enable competency-based training to use hand-held medical devices
2. Clinical criteria - adults who have previously received a kidney transplant and are clinically well with stable kidney transplant function, based upon assessment by their consultant nephrologist
3. Aged 18 years or older
4. Capacity to consent to take part in study

Exclusion Criteria

1. Patients not meeting inclusion criteria
2. Pregnancy
3. Clinical instability or drug changes within previous 4 weeks
4. Participants currently taking part in another research study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The feasibility, safety and accuracy of patients self-testing their kidney function from capillary blood samples using ISTAT Alinity devices at home, when compared to blood samples obtained and tested by study nurses using both i-STAT Alinity devices and NHS laboratory analysis. This will be measured from baseline to the end of study at week 4.
Secondary Outcome Measures
NameTimeMethod
<br> 1. Patient experience, acceptability and usability, assessed through diary, questionnaires and interview analysis from baseline until the end of study interviews<br> 2. Economic viability of patient self-testing kidney function at home, assessed through analysis of questionnaires, interviews and care pathway analysis from baseline until the end of study interviews<br> 3. Complications and adverse events: the nature and frequency of device-specific and non-device events collected by direct questioning of the patient on a weekly basis when they attend clinic and note review where necessary. This is from the baseline visit until week 4<br>
© Copyright 2025. All Rights Reserved by MedPath